Jun 29, 2020 / 05:00PM GMT
Operator
Good day, ladies and gentlemen, and welcome to your Acasti Pharma Fiscal Year 2020 Business Update Conference Call. (Operator Instructions)
At this time, it is my pleasure to turn the floor over to your host, [Alexandra Body], Investor Relations. Ma'am, the floor is yours.
Unidentified Company Representative -
Thank you. Good afternoon, everyone, and welcome to Acasti Pharma's Fourth Quarter and Year-End Fiscal 2020 Conference Call. On the call with us today are Jan D' Alvise, President and CEO. Pierre Lemieux, Chief Operating Officer, Chief Scientific Officer and Co-Founder; Brian Groch, Chief Commercial Officer; and Jean-François Boily, Vice President, Finance.
If you have any questions after the call or would like any additional information about the company, please contact Crescendo Communications at (212) 671-1020. I'd also like to remind everyone that statements on this conference call that are not statements of historical or current facts constitute forward-looking information within the meaning of Canadian securities laws, forward-looking
Q4 2020 Acasti Pharma Inc Earnings Call Transcript
Jun 29, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers